Medtronic Cardiac Surgery

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medtronic Cardiac Surgery sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 2 completed later-stage tilt upper quartile by trial count

Medtronic Cardiac Surgery: 7 sponsored US clinical trials, 2 recruiting.

Medtronic Cardiac Surgery sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Left Atrial Appendage Exclusion, with 1 trials.

Upper-quartile sponsor footprint

Medtronic Cardiac Surgery sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Where Medtronic Cardiac Surgery enrollment is open (later-stage tilt)

2 recruiting of 7 indexed (29% open); 2 completed (29%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Left Atrial Appendage Exclusion (1 trial), 7 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medtronic Cardiac Surgery: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Medtronic Cardiac Surgery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Medtronic Cardiac Surgery3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Medtronic Cardiac Surgery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-07-11 snapshot).

Medtronic Cardiac Surgery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

What to do with this Medtronic Cardiac Surgery page

7 registered trials is a research-attention snapshot, not an endorsement of Medtronic Cardiac Surgery or any single study.

  • 2 of Medtronic Cardiac Surgery's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Left Atrial Appendage Exclusion is the condition Medtronic Cardiac Surgery studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Left Atrial Appendage Exclusion trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medtronic Cardiac Surgery pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.